Add Yahoo as a preferred source to see more of our stories on Google. Waking up with some gunk in your eyes is usually nothing to worry about. The scientific name for this crust is rheum, and it forms ...

Eric D. Donnenfeld, MD; underscores the significance of an FDA approved treatment for Demodex blepharitis as well as past alternative treatments. This is a video synopsis/summary of an Insights ...

Looking to fix your problems in the blink of an eye? Spraying an acid onto your peepers isn’t exactly intuitive. But it might ...

An overview of the current landscape of available treatment options for Demodex blepharitis is analyzed. This is a video synopsis/summary of a discussion involving Elizabeth Yeu, MD. Yeu discusses how ...

The treatment of blepharitis focuses on alleviating symptoms, addressing underlying causes, and preventing complications. [iStockphotos] Blepharitis is a common chronic condition that affects the ...

The approval was obtained by Grand Pharmaceutical Group Limited (“Grand Pharma”), Tarsus’ exclusive partner for the development and commercialization of TP-03 for the treatment of Demodex blepharitis ...

NMPA authorization establishes a first-in-region, mechanism-based option for Demodex blepharitis in Greater China, where ...

The FDA approved lotilaner ophthalmic solution 0.25% (Xdemvy) as the first specific treatment for Demodex blepharitis. Lotilaner (formerly TP-03) is an ectoparasiticide that targets Demodex mites, ...

Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States. Despite being common, it is frequently underdiagnosed or mistaken for ...

Shares in Grand Pharma tumbled today despite the Chinese drugmaker being given the greenlight to take its first-in-class eye ...